Providence researcher plays key role in NASA twins study

April 17, 2019

Share this Article
Facebook
Twitter
Email
LinkedIn

Identical twin astronauts – one grounded on Earth and the other launched into space – proved to be fascinating research subjects for Providence genomics expert and cancer researcher Brian Piening, Ph.D., who helped NASA explore the effects of long-term space missions on the body. Dr. Piening now uses what he learned to personalize treatment for cancer patients at Providence.

In a rare procedure, a Providence patient gets a new jaw, complete with teeth, in one day

A Providence patient gets a new jaw, complete with teeth, in one day

Breast cancer immunotherapy breakthrough

Providence Cancer Institute’s commitment to advancing immunotherapy research and clinical trials is, again,...

Other content in this Stream

Providence forensic nurses care for patients and community

Providence researcher plays key role in NASA twins study

Previous Article

Next Article

Other content in this Stream

Providence’s forensic nurse examiner team care for some of our most vulnerable patients in their most desperate times. See all they do and why they do it.

Dr. Jianguo Huang to lead the Preclinical Cancer Therapy Laboratory with a focus on bridging sarcoma research and immunotherapy

Providence researcher awarded National Institutes of Health grant to lead a new lab focusing on the discovery of novel inflammatory pathways in cancer that are targets for therapeutic intervention.

When we talk about how Providence helps others, you might think first of health care for patients. But there are many more ways we support people in our communities.

Leading healthcare professionals interested in the treatment of patients with neuroendocrine tumors to gather in June for a comprehensive medical conference held in Oregon.

Two investigator-initiated trials sponsored by the Earle A. Chiles Research Institute are currently recruiting patients with either advanced HER2-positive or HR positive/HER2 negative breast cancer.

Providence researchers recruit adult patients with solid cancers for phase I clinical trial of genetically engineered, adoptively transferred T cells.

Providence St. Vincent Medical Center and Oregon Nurses Association labor negotiation teams are pleased to announce that we have have reached a tentative agreement.

Adoptive cell therapy study at Providence Cancer Institute gives hope to woman with metastatic pancreatic cancer. Results may lead to new treatments and longer lives for people with advanced cancers.

A Florida woman with advanced pancreatic cancer is hopeful after receiving an experimental treatment in a clinical trial at Providence Cancer Institute that shrunk her tumors.

Ovarian Cancer Alliance and Providence Cancer Institute to host free education event on June 29 for ovarian cancer patients and their caregivers.

May 20 is International Clinical Trials Day. Clinical trials are evidence-based studies in people that result in the biggest breakthroughs in cancer research.

Two new clinical trials available at Providence will evaluate whether a combination of medications are effective and safe therapies for people with metastatic melanoma and metastatic uveal melanoma.

Researchers of the Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, will present their latest cancer immunotherapy data at Immunology2022 in May.

Providence Chief Executive of Behavior Health Robin Henderson shares how to protect your mental health in the face of global problems.

Investigator-initiated clinical trial at Providence Cancer Institute to evaluate the safety and efficacy of using a combination of immunotherapy and radiation therapy on tumors.

You can donate a bike to any one of 23 locations throughout the Portland Metro area, including 11 Providence locations, from 9 a.m. to 1 p.m. on April 30.

Register for a free virtual education event on April 19 for Mantle Cell Lymphoma patients, presented by the Leukemia & Lymphoma Society (LLS) and Providence Cancer Institute of Oregon.

A new phase I clinical trial available at Providence Cancer Institute of Oregon will evaluate the efficacy of new immunotherapy designed to modulate the immune system in blood cancer patients.

Providence Cancer Institute of Oregon and Pancreatic Cancer Action Network are partnering to promote awareness and research for pancreatic cancer through two community events this April.